Nuclein

Austin, TX · Founded 2017 · Privately Held (backing)

Developer of a rapid PCR testing system designed to deliver lab results at the point of care. Nuclein is based in Austin, TX and was founded in 2017. It has raised $67.3 million across 5 recorded rounds; the latest was a $1.3 million debt round in Jun 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$67.3M
Last round
Debt
Jun 2026

Who backs Nuclein?

9 investors
InvestorType
Alan RicheyAngel
ACC Bioscience Incubator—
David Shockley—
Dr. John Butler—
Jason Dorsey—
Joseph Aragona—
Northwestern University—
Trinity Investors—
William Cunningham—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Nuclein investors

9 investors are on record for Nuclein, including Alan Richey, ACC Bioscience Incubator, David Shockley and Dr. John Butler. The debt round in Jun 2026 drew 2 investors.

Free account
More of Nuclein with a free account
  • ·Watch Nuclein: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Nuclein. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View